15,357
Participants
Start Date
January 1, 2024
Primary Completion Date
April 30, 2025
Study Completion Date
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing
Liaoning Chengda Biotechnology CO., LTD
INDUSTRY